Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax toxin receptor proteins.

Kenneth A Bradley1, John A T Young

  • 1McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, 1400 University Avenue, Madison, WI 53706, USA. kbradley@microbio.ucla.edu

Biochemical Pharmacology
|January 16, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A bacterial genotoxin reveals a p53-proteasome-LC3 regulatory axis that drives the suppression of autophagy in cells experiencing sublethal DNA damage.

iScience·2025
Same author

Antiviral target compound profile for pandemic preparedness.

Nature reviews. Drug discovery·2024
Same author

Author Correction: A novel antibiotic class targeting the lipopolysaccharide transporter.

Nature·2024
Same author

Autophagy suppression in DNA damaged cells occurs through a newly identified p53-proteasome-LC3 axis.

bioRxiv : the preprint server for biology·2024
Same author

A novel antibiotic class targeting the lipopolysaccharide transporter.

Nature·2024
Same author

Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus.

Journal of medicinal chemistry·2023
Same journal

Unraveling the multifaceted roles of the aryl hydrocarbon receptor in the central nervous system: neurogenesis, neural function, and disease.

Biochemical pharmacology·2026
Same journal

4-DMB, a diclofenac derivative, alleviates DSS-induced ulcerative colitis in mice by binding TNFR1 to inhibit inflammation.

Biochemical pharmacology·2026
Same journal

Calceolarioside B alleviates airway barrier dysfunction and inflammation via targeting P2Y<sub>6</sub>R in OVA-triggered asthma.

Biochemical pharmacology·2026
Same journal

The dual-faced pyruvate kinase M2 in tumors: From cytoplasmic metabolic gatekeeper to nuclear transcriptional coactivator.

Biochemical pharmacology·2026
Same journal

A [<sup>68</sup>Ga]-labeled PDGFRβ-targeting peptide PET probe for assessing MASH-related fibrosis in diet-induced preclinical models and human liver specimens.

Biochemical pharmacology·2026
Same journal

Targeting TAK1 to overcome cisplatin resistance in lung adenocarcinoma by rewiring the NF-κB and p53 signaling.

Biochemical pharmacology·2026
See all related articles

Researchers identified the anthrax toxin receptor (ATR), encoded by the TEM8 gene, which is crucial for Bacillus anthracis infection. This discovery opens new avenues for anthrax antitoxin development and cancer research.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Cancer Biology

Background:

  • Bacillus anthracis toxin is a critical factor in anthrax pathogenesis.
  • The cellular receptor for anthrax toxin (ATR) was recently identified.
  • ATR is a type I transmembrane protein containing an integrin-like inserted (I) domain.

Purpose of the Study:

  • To discuss the known information about the anthrax toxin receptor (ATR).
  • To explore the application of ATR knowledge in developing anthrax treatments.
  • To understand the role of ATR in cancer biology.

Main Methods:

  • Identification of the anthrax toxin receptor (ATR).
  • Characterization of the ATR protein structure and function.
  • Investigation of the ATR gene (TEM8) expression patterns.

Related Experiment Videos

Main Results:

  • The ATR I domain serves as the toxin binding site.
  • A soluble form of the ATR I domain demonstrated effective antitoxin properties.
  • The TEM8 gene, encoding ATR, is upregulated in tumor vasculature, suggesting a role in angiogenesis.

Conclusions:

  • The identification of ATR provides a target for developing novel anthrax antitoxins.
  • ATR's role in angiogenesis suggests potential applications in cancer therapy.
  • Understanding ATR advances research in anthrax pathogenesis and cancer biology.